Use of rituximab plus lenalidomide for the treatment of follicular lymphoma in Ontario, Canada

Summary

Client: Hoffmann-La Roche Limited

Project ID: P2023-203/ 2025 0970 389 000

Research Question/Objectives: How many follicular lymphoma (FL) patients have received R-Len (Rituximab plus lenalidomide combination), year-over-year, between 2018 and 2023?

Objectives:

The aims for this analysis are to identify FL patients receiving this R-Len regimen in the linked data.

Status: Completed

Results: July 2025

Information

Project ID

P2023-203/ 2025 0970 389 000

Status

Completed

Private Sector Project

2024

An observational study to characterize asthma and severe asthma care and burden across a Canadian population

Private Sector Project

2024

Burden of pertussis and associated complications among adults in Ontario, Canada

Private Sector Project

2024

CHEERLEADER Study: Understanding characteristics, treatment patterns, clinical outcomes, healthcare resource utilization, and costs among patients with de novo muscle-invasive bladder cancer in Canada